Spectrum of Mutations in Kidney, Stomach, and Liver From lacl Transgenic Mice Recovered After Treatment With Tris(2,3-Dibromopropyl)phosphate

Environmental and Molecular Mutagenesis

Volumn 28, Issue 4, 1996, Pages 418-423

  De Boer, Johan G ^a   Mirsalis, Jon C ^b   Provost, G Scott ^c   Tindall, Kenneth R ^d   Glickman, Barry W ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b SRI INTERNATIONAL   (United States)

^c Stratagene   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Big Blue ; DNA sequencing; Mutational frequency; Mutational spectra; Tissue specificity

Indexed keywords

ANIMALIA; GOSSYPIUM HIRSUTUM; MUS MUSCULUS; RODENTIA;

BACTERIAL PROTEIN; ESCHERICHIA COLI PROTEIN; LACI PROTEIN, BACTERIA; ORGANOPHOSPHATE; PHOSPHORIC ACID TRIS(2,3 DIBROMOPROPYL) ESTER; REPRESSOR PROTEIN; TRIS(2,3-DIBROMOPROPYL)PHOSPHATE;

ANIMAL; ARTICLE; DNA SEQUENCE; DRUG EFFECT; GENETICS; KIDNEY; LIVER; MALE; METABOLISM; MOUSE; MUTATION; STOMACH; TRANSGENIC MOUSE;

ANIMALS; BACTERIAL PROTEINS; ESCHERICHIA COLI PROTEINS; KIDNEY; LIVER; MALE; MICE; MICE, TRANSGENIC; MUTATION; PHOSPHORIC ACID ESTERS; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; STOMACH;

EID: 0030329708     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2280(1996)28:4<418::aid-em17>3.0.co;2-i     Document Type: Article

References (24)

1. Adams WT, Skopek TR (1987): Statistical test for the comparison of samples from mutational spectra. J Mol Biol 194:391-396.
2. An J, Hsie AW (1994): Polymerase chain reaction-directed DNA sequencing of bleomycin-induced "nondeletion"-type, 6-thioguanine-resistant mutants in Chinese hamster ovary cell derivative AS52: Effects of an inhibitor and a mimic of superoxide dismutase. Environ Mol Mutagen 23:101-109.
3. Blum A, Ames BN (1977): Flame retardant additives as possible cancer hazards. The main flame retardant in children's pyjamas is a mutagen and should not be used. Science 195:17-23.
4. Carr GJ, Gorelick NJ (1994): Statistical tests of significance in transgenic mutation assays: Consideration on the experimental unit. Environ Mol Mutagen 24:276-282.
5. Carr GJ, Gorelick NJ (1995): Statistical design and analysis of mutation studies in transgenic mice. Environ Mol Mutagen 25:246-255.
6. Cunningham ML, Elwell MR, Matthews HB (1993): Site-specific proliferation in renal tubular cells by the renal tubular carcinogen tris(2,3-dibromopropyl)phosphate. Environ Health Perspect 101 (Suppl 5):253-257.
7. Cunningham ML, Elwell MR, Matthews HB (1994): Relationship of carcinogenicity and cellular proliferation induced by mutagenic noncarcinogens vs. carcinogens. III. Organophosphate pesticides vs. tris(2,3-dibromopropyl)phosphate. Fundam Appl Toxicol 23:363-369.
8. Erfle HL, Walsh DF, Holcroft J, Hague N, de Boer JG, Glickman BW (1996): An efficient laboratory protocol for the sequencing of large numbers of lacl mutants recovered from Big Blue® transgenic animals. Environ Mol Mutagen 28:393-396.
9. Mirsalis JC, Hamer JD, O'Loughlin KG, Winegar RA, Short JM (1993): Effects of nongenotoxic carcinogens on hepatic mutations in lacl transgenic mice. Environ Mol Mutagen 21 (Suppl 22):48.
10. NCI, National Cancer Institute (1978): "Bioassay of Tris(2,3-dibromopropyl)phosphate for Possible Carcinogenicity." Washington DC: US Government Printing Office.
11. Pearson PG, Omichinski JG, McClanahan RH, Soderlund EJ, Dybing E, Nelson SD (1993): Metabolic activation of tris(2,3-dibromopropyl)phosphate to reactive intermediates. 1. Covalent binding and reactive metabolite formation in vitro. Toxicol Appl Pharmacol 118:186-195.
12. Prival MJ, McCoy EC, Gutter B, Rozenkranz HS (1977): Tris(2,3-dibromopropyl)phosphate: Mutagenicity of a widely used flame retardant. Science 195:76-78.
13. Provost GS, Kretz PL, Hamner RT, Matthews CD, Rogers BJ, Lundberg KS, Dycaico MJ, Short JM (1993): Transgenic systems for in vivo mutation analysis. Mutat Res 288:133-149.
14. Reznik G, Ward JM, Hardisty JF, Russfield A (1979): Renal carcinogenic and nephrotoxic effects of the flame retardant tris(2,3-dibromopropyl)phosphate in F344 rats and (C57B1/6NxC3H/ HeN)F1 mice. J Natl Cancer Inst 63:205-212.
15. Rideout WM, Coetzee GA, Olumi AF, Jones PA (1990): 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249:1288-1290.
16. Rogers BJ, Provost GS, Young RR, Putman DL, Short JM (1995): Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacl transgenic mouse mutagenesis assay (I). Mutat Res 327:57-66.
17. Short JM, Kohler SW, Provost GS, Feick A, Kretz PL (1990): The use of lambda phage shuttle vectors in transgenic mice for development of a short term mutagenicity assay. In: "Mutation and the Environment. Part A." New York: Wiley-Liss, pp 355-367.
18. Simula TP, Glancey MJ, Soderlund EJ, Dybing E, Wolf CR (1993): Increased mutagenicity of 1,2-dibromo-3-chloropropane and tris(2,3-dibromopropyl)phosphate in Salmonella TA100 expressing human glutathione S-transferases. Carcinogenesis 14:2303-2307.
19. Soderlund EJ, Nelson SD, Dybing E (1981): In vitro and in vivo covalent binding of the kidney toxicant and carcinogen tris(2,3-dibromopropyl)phosphate. Toxicology 21:291-304.
20. Soderlund EJ, Brunborg G, Dybing E, Trygg B, Nelson SD, Holme JA (1992): Organ-specific DNA damage of tris(2,3-dibromopropyl)-phosphate and its diester metabolite in the rat. Chem Biol Interact 82:195-207.
21. Van Beerendonk GJ, Nivard MJ, Vogel EW, Nelson SD, Meerman JHN (1992): Formation of thymine adducts and crosslinking potential of 2-bromoacrolein, a reactive metabolite of tris(2,3-dibromopropyl)phosphate. Mutagenesis 7:19-24.
22. Van Beerendonk GJ, Nelson SD, Meerman JHN (1994a): Metabolism and genotoxicity of the halogenated alkyl compound tris(2,3-dibromopropyl)phosphate. Hum Exp Toxicol 13:861-865.
23. Van Beerendonk GJ, Nivard MJ, Vogel EW, Nelson SD, Meerman JHN (1994b): Genotoxicity of the flame retardant tris(2,3-dibromopropyl)phosphate in the rat and Drosophila: Effects of deuterium substitution. Carcinogenesis 15:1197-1202.
24. Van Duuren BL, Loewengart G, Seidman I, Smith AC, Melchionne S (1978): Mouse skin carcinogenesis test of the flame retardants tris(2,3-dibromopropyl)phosphate, tetrakis(hydroxymethyl)phosphonium chloride and polyvinylbromide. Cancer Res 38:3236-3240.